RDIF, Panacea Biotec launch production of Sputnik V vaccine in India; set to produce 10 mn doses per year
3 years, 7 months ago

RDIF, Panacea Biotec launch production of Sputnik V vaccine in India; set to produce 10 mn doses per year

Firstpost  

The first batch of the COVID-19 vaccine produced at Panacea Biotec’s facilities at Baddi in Himachal Pradesh will be shipped to Russia’s Gamaleya Center for quality control New Delhi: The Russian Direct Investment Fund and Indian drug firm Panacea Biotec on Monday announced the launch of the production of the Sputnik V coronavirus vaccine in India. The first batch of the COVID-19 vaccine produced at Panacea Biotec’s facilities at Baddi in Himachal Pradesh will be shipped to Russia’s Gamaleya Center for quality control. “Launch of production in India in partnership with Panacea Biotec marks an important step in helping the country fight the pandemic,” RDIF chief executive Kirill Dmitriev said. On the development, Panacea Biotec MD Rajesh Jain said, “This marks a significant step as we initiate production of Sputnik V. Together with RDIF, we hope to help bring a sense of normalcy back to people across the country and around the world.” Sputnik V was registered in India under the emergency use authorisation procedure on 12 April, 2021, and vaccination against coronavirus with the Russian vaccine started on 14 May.

India Russia Production Vaccine Panacea Biotec Panacea Biotec Rdif Sputnik V  sputnik  v  set  production  panacea  mn  coronavirus  rdif  step  biotec  vaccine  launch  shipped  produce

History of this topic

India eyes to increase oral polio vaccine supply
8 months ago

India eyes to increase oral polio vaccine supply

Live Mint  

New Delhi: The Centre is looking to increase the manufacturing capacity of oral polio vaccine, said Union Health and Family Welfare Secretary Apurva Chander. "An agreement has been signed under which Bharat Biotech will procure drug substances for manufacturing oral polio vaccines to be supplied within India and globally. With this partnership, the capacity of BBIL to manufacture Oral Polio …

With State prod, India can be world leader in vaccines
10 months, 4 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

India restarts Covid vaccine production as new infections soar 30% in one day
1 year, 8 months ago

India restarts Covid vaccine production as new infections soar 30% in one day

The Independent  

India is ramping up its vaccine production following a rapid surge in Covid-19 cases driven by a new subvariant dubbed Arcturus. The country recorded 10,158 news Covid cases on Thursday, a 30 per cent surge in one day, according to the federal health ministry data. The company stopped manufacturing Covishield in December 2021 due to dwindling demand and a low …

India launches world’s 1st intranasal Covid vaccine: Check price, availability
1 year, 10 months ago

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Hindustan Times  

The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world. "As the world's first intranasal Covid-19 vaccine, this is a glorious …

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched
1 year, 10 months ago

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched

Live Mint  

Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched India's first made nasal vaccine against Covid-19 iNCOVACC. "Our nasal vaccine will be officially launched on January 26, on Republic Day," the company's chairman and managing director Krishna Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organised at the …

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
1 year, 10 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?
1 year, 11 months ago

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?

Firstpost  

The Indian pharmaceuticals industry showed resilience, speed, and reliability in dealing with the COVID-19 pandemic challenges in India and provided much-needed aid to many other countries. With rising inflation in many countries and the recent surge in COVID-19 cases in China, the Indian pharmaceuticals industry is awaiting strong policy measures to provide further impetus to continue the ‘Make in India’ …

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today
1 year, 11 months ago

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya will launch 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday, official sources said. According to the sources, Hyderabad-based Bharat Biotech's Intranasal heterologous booster dose is likely to be available in the market by February first week.Recently, Bharat Biotech announced iNCOVACC® as a booster dose in the country.Earlier this …

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
1 year, 11 months ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18  

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
1 year, 11 months ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News  

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

A PLI-type scheme for 'atmanirbhar' vaccine industry
2 years ago

A PLI-type scheme for 'atmanirbhar' vaccine industry

Live Mint  

The government will likely unveil a ₹2,500 crore financial assistance programme to boost domestic production of vaccine raw materials to enhance self-reliance amid a resurgence of covid cases worldwide, two officials familiar with the development said. Cement investors see Q3 with mixed feelings While India is a global leader in vaccine production, it imports key raw materials needed for manufacturing. …

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal
2 years ago

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal

Deccan Chronicle  

Hyderabad: Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to get vaccination certificate. The company sources said Bharat Biotech is currently holding discussions with international “potential partners” who have approached the company for manufacturing and distribution of the intranasal vaccine globally. “Since iNCOVACC has …

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval
2 years, 3 months ago

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval

The Hindu  

Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine has been approved by Central Drugs Standard Control Organisation for primary immunization against COVID-19 in 18+ age group for restricted use in emergencies, Health Minister Mansukh Mandaviya tweeted on Tuesday. Dr. Krishna Ella, chairman and managing director, Bharat Biotech, said: “iNCOVACC will be a global game changer in intra-nasal vaccines technology and delivery …

Monkeypox Scare: Prepared to Import Smallpox Vaccines At Risk At My Cost, Says SII's Adar Poonawalla
2 years, 4 months ago

Monkeypox Scare: Prepared to Import Smallpox Vaccines At Risk At My Cost, Says SII's Adar Poonawalla

News 18  

Serum Institute of India CEO Adar Poonawalla on Tuesday said his Pune-based pharmaceutical company is ready to import a few million doses of a Danish smallpox vaccine at “risk at his cost” amid the scare over the larger breakout of monkeypox infection in the country. Poonawalla, whose firm SII manufactured the Oxford-AstraZeneca vaccine Covishield to fight Covid-19, mentioned that no …

India’s ‘other’ COVID vaccines: Status of under-trial & approved but unused jabs
2 years, 7 months ago

India’s ‘other’ COVID vaccines: Status of under-trial & approved but unused jabs

The Hindu  

As India nears the 200-crore COVID-19 vaccination mark, Serum Institute of India’s Covishield accounts for 80 per cent of the jabs, while Bharat Biotech’s Covaxin accounts for 16.75 per cent jabs. As of date, India has granted emergency usage authorisation to nine COVID-19 vaccine candidates in total – Covishield, Covaxin, Covovax, Corbevax, Zydus Cadila’s ZyCoV-D, Moderna’s Spikevax, Sputnik-V, Sputnik Light, …

Covid-19: 10 Crore Doses of SII's Covovax Approved for Exports by Govt Lab, Stock Rolled Out for Teens
2 years, 7 months ago

Covid-19: 10 Crore Doses of SII's Covovax Approved for Exports by Govt Lab, Stock Rolled Out for Teens

News 18  

The country’s apex laboratory has cleared more than 10 crore doses of Covovax, another Covid-19 vaccine by the Serum Institute of India, for exports even as India gears up to roll out the shots to inoculate teenagers, News18.com has learnt. According to government data, the Central Drugs Laboratory in Kasauli, Himachal Pradesh has so far approved a little over 10 …

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla

India Today  

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that Covid-19 vaccines that are made in India, have provided more protection against coronavirus infection than vaccines like Pfizer and Moderna. Speaking to news agency ANI, Poonawalla said, "The Covid-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and …

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla

Firstpost  

The COVID-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna, said Adar Poonawalla New Delhi: Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that “Made in India” COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna. “The …

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO
2 years, 8 months ago

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO

Hindustan Times  

Chief executive officer of Serum Institute of India Adar Poonawalla on Tuesday said the company has a stockpile of 200 million doses of Covishield, while it has already exported 40 million doses of Covovax to European countries and Australia. Serum Institute of India CEO Adar Poonawalla speaks at the 'AIMA Leadership Conclave' in New Delhi on Tuesday, "We have a …

Weighing the choices: on precautionary vaccine doses
2 years, 8 months ago

Weighing the choices: on precautionary vaccine doses

The Hindu  

As India sees a steady slump in its daily coronavirus count, the Centre has announced opening up the third, or ‘precautionary doses’, to everyone over 18 years. A major aspect of vaccines is the risk of adverse events following vaccination, and previous experience has suggested that certain vaccines may induce a higher risk of blood clots in younger populations. With …

Russia registers nasal version of Sputnik V, world's first nasal vaccine against COVID-19
2 years, 8 months ago

Russia registers nasal version of Sputnik V, world's first nasal vaccine against COVID-19

India Today  

The Russian Health Ministry has registered the nasal version of its vaccine against coronavirus - Sputnik V. It is the world's first nasal vaccine against COVID-19. The Russian news agency TASS in January reported that the nasal vaccine against the novel coronavirus infection will be in civil circulation and available for Russians within 3-4 months, quoting the director of the …

Govt panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose
2 years, 9 months ago

Govt panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose

India Today  

An expert panel of India’s central drug authority has recommended permission to conduct a phase-3 clinical trial of the single-dose Covid-19 vaccine ‘Sputnik Light’ as a booster dose, official sources said on Saturday. "The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation, which reviewed the application on Friday after detailed deliberation, recommended granting permission for the …

Covid-19 Vaccine Sputnik V's India Production In A Fix After Sanctions on Russia's Jab Manufacturer
2 years, 9 months ago

Covid-19 Vaccine Sputnik V's India Production In A Fix After Sanctions on Russia's Jab Manufacturer

News 18  

The sanctions imposed by the United States on the Russian Direct Investment Fund, which markets Sputnik V internationally has raised concerns over the manufacturing of the Covid-19 vaccine in India, the second largest producer of the jab after Russia. RDIF is Russia’s sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and …

Covid-19 | India Likely To Supply Covovax, Corbevax Vaccines To Quad Partners: Report
2 years, 10 months ago

Covid-19 | India Likely To Supply Covovax, Corbevax Vaccines To Quad Partners: Report

ABP News  

New Delhi: India on Friday conveyed to the Quad partners that New Delhi is open to supplying Covid-19 vaccines, including Covovax and Corbevax, manufactured in the country under the vaccine partnership. “As pandemic continues to impact us, we have undertaken collective efforts to address global health security, Quad vaccine initiative and our collective vaccine delivery. Australian Foreign Minister Marise Payne …

India’s first mRNA COVID-19 vaccine likely to be rolled out by April
2 years, 10 months ago

India’s first mRNA COVID-19 vaccine likely to be rolled out by April

The Hindu  

Data from human trials of India’s first homegrown mRNA COVID-19 vaccine are likely to be presented to authorities for evaluation by the end of the month, and company officials are aiming to roll out the product before April, two senior scientists connected to the Department of Biotechnology told The Hindu. The mRNA vaccine being developed by Pune-based Gennova Biopharmaceuticals is …

Single-dose Sputnik Light Covid vaccine gets approval for emergency use in India
2 years, 10 months ago

Single-dose Sputnik Light Covid vaccine gets approval for emergency use in India

India Today  

The Drugs Controller General of India has granted emergency-use permission to the single-dose Sputnik Light COVID-19 vaccine on Sunday. DCGI has granted emergency use permission to Single-dose Sputnik Light COVID-19 vaccine in India. — Dr Mansukh Mandaviya February 6, 2022 An expert panel of India's central drug authority on Friday recommended granting restricted emergency use authorisation to the single-dose Covid-19 …

Centre Places Purchase Order For 5 Crore Doses Of Corbevax Covid-19 Vaccine: Report
2 years, 10 months ago

Centre Places Purchase Order For 5 Crore Doses Of Corbevax Covid-19 Vaccine: Report

ABP News  

New Delhi: The Central Government has placed an order with Hyderabad-based Pharmaceutical business Biological E for five crore doses of the 'Corbevax' COVID-19 vaccine, with each dosage costing Rs 145, according to the reports. “In this regard, it is also stated that Rs 1,500 crores has been released as advance vide sanction order dated June 2, 2021, to HLL Lifecare …

6 Crore Corbevax, 3 Crore Covovax Doses Cleared by Govt Lab; Panel Nod Awaited for Use Among Kids in India
2 years, 10 months ago

6 Crore Corbevax, 3 Crore Covovax Doses Cleared by Govt Lab; Panel Nod Awaited for Use Among Kids in India

News 18  

The Central Drugs Laboratory, India’s apex lab, has cleared stock of 6 crore Corbevax doses, the Covid-19 vaccine manufactured by Hyderabad-based Biological E, News18.com has learnt. Apart from Corbevax, the laboratory has also cleared 3.15 crore doses of Covovax — an American vaccine manufactured by Serum Institute of India — and 1.85 crore doses of Johnson & Johnson’s single-shot Covid-19 …

Trying to Bring Sputnik M Vaccine for Adolescents to India: Dr Reddy's
2 years, 10 months ago

Trying to Bring Sputnik M Vaccine for Adolescents to India: Dr Reddy's

News 18  

Dr Reddy’s Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia’s Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, to India. Addressing a press conference after announcing the company’s Q3 results, a senior executive of the drug maker said Phase 3 clinical trial data of Russia’s single dose COVID-19 vaccine Sputnik …

India's Covid-19 vaccination drive, one year on | Recap
2 years, 11 months ago

India's Covid-19 vaccination drive, one year on | Recap

India Today  

One year ago, India set out on the challenging journey of vaccinating its massive 1.38 billion-strong population against Covid-19. In the year since the country’s vaccination drive began, 90 per cent of the eligible population has received the first dose and 60 per cent has got their second dose too. More than 156 crore vaccine doses have been administered in …

Biological E Aims to Produce 100 Mn Doses/month of Corbevax from Feb 2022
2 years, 11 months ago

Biological E Aims to Produce 100 Mn Doses/month of Corbevax from Feb 2022

News 18  

Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the city-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday. “Biological E. Limited plans to complete production at a …

In Boost to India's Covid Fight, 2 Vaccines, Covovax & Corbevax, and 1 Anti-Viral Pill Cleared in a Single Day
2 years, 11 months ago

In Boost to India's Covid Fight, 2 Vaccines, Covovax & Corbevax, and 1 Anti-Viral Pill Cleared in a Single Day

News 18  

Expanding India’s vaccine basket, the Central Drug Authority has approved the Serum Institute of India’s COVID-19 vaccine Covovax, Biological E’s jab Corbevax and anti-Covid pill Molnupiravir for restricted use in emergency situation. It also had recommended granting restricted emergency use approval to the drug Molnupiravir for treatment of adult patients with COVID-19 and who have high risk of progression of …

India Supplied Over 983 Lakh Covid-19 Vaccine Doses to 94 Countries, 2 UN Entities Till Dec 15: Govt
3 years ago

India Supplied Over 983 Lakh Covid-19 Vaccine Doses to 94 Countries, 2 UN Entities Till Dec 15: Govt

News 18  

India has supplied 983.068 lakh doses of COVID-19 vaccine to 94 countries and two United Nations entities in the form of grant, commercial export or through COVAX till December 15 since the start of Vaccine Maitri programme in January, 2021, the Rajya Sabha was told on Tuesday. The country supplied COVID-19 related medical and other assistance to over 150 countries …

India Likely to be Left With Surplus Covid-19 Vaccines in December: Report
3 years, 1 month ago

India Likely to be Left With Surplus Covid-19 Vaccines in December: Report

News 18  

India will perhaps have a huge stock of surplus Covid-19 vaccine by December end since production capacity has been amped up to a great degree, and the total vaccines required to inoculate the Indian adult population next month is only 15.63 crore. According to a Times of India report, at least 31 crore Covid vaccines are likely to be produced …

What Went Wrong with Full Rollout of Russia’s Sputnik V Vaccine in India
3 years, 1 month ago

What Went Wrong with Full Rollout of Russia’s Sputnik V Vaccine in India

News 18  

Slower than anticipated production of the second dose of Sputnik V, heavy cold storage requirements, pending WHO approval, rising Covid-19 cases in Russia and low demand at private hospitals have put brakes on the complete rollout of the Russian vaccine in India. It means that only one second dose is manufactured for every 5 first doses manufactured.” According to experts …

Coronavirus News LIVE Updates: India to Ship Vaccines to COVAX In a Few Weeks, Says Report
3 years, 1 month ago

Coronavirus News LIVE Updates: India to Ship Vaccines to COVAX In a Few Weeks, Says Report

News 18  

Coronavirus News LIVE Updates: India could resume deliveries of COVID-19 shots to global vaccine-sharing platform COVAX in a few weeks for the first time since April, two health industry sources told Reuters, ending a suspension of supplies that has hurt poor countries. After the US lifted travel restrictions put in place in 2020, Paul Campbell had waited nearly two years …

Explained | Why are U.S. COVID-19 vaccines still out of reach in India?
3 years, 1 month ago

Explained | Why are U.S. COVID-19 vaccines still out of reach in India?

The Hindu  

The story so far : More than six months after the government announced it would fast-track clearances for foreign COVID-19 vaccines to India, the indemnity clause is still holding up the import of all American vaccines to India, including those manufactured by Pfizer, Johnson & Johnson and Moderna. If it all any indemnity is to be granted to any company …

Corbevax Samples Cleared by Kasauli Lab, Paving Way for Stockpiling, Vaccine May Hit Market in December
3 years, 1 month ago

Corbevax Samples Cleared by Kasauli Lab, Paving Way for Stockpiling, Vaccine May Hit Market in December

News 18  

A batch of Hyderabad-based pharmaceutical firm Biological E’s Covid vaccine Corbevax has been cleared by the country’s apex testing laboratory in Himachal Pradesh, paving the way for the manufacturer to start stockpiling, News18.com has learnt. The Central Drugs Laboratory in Kasauli on Tuesday cleared the first lot of Corbevax vaccine, which was sent for testing before Biological E can kickstart …

Covid-19: J&J's Hyderabad-made Jabs Get CDL Nod, Over 1 Cr Doses Ready for Export
3 years, 1 month ago

Covid-19: J&J's Hyderabad-made Jabs Get CDL Nod, Over 1 Cr Doses Ready for Export

News 18  

American pharma giant Johnson & Johnson’s Covid-19 vaccine shots, manufactured in India by Hyderabad-based Biological E, are ready for export, News18.com learnt. “Once the Drug Controller General of India approves the report sent by CDL and the request filed by the company, the batches can be exported.” The move is in line with Prime Minister Narendra Modi’s announcement at the …

Could quality concerns over Novavax's Covid vaccine in US mount trouble for Covovax in India?
3 years, 1 month ago

Could quality concerns over Novavax's Covid vaccine in US mount trouble for Covovax in India?

India Today  

Novavax is struggling to secure an emergency use authorisation from the United States Food And Drug Administration for its Covid-19 vaccine as questions have been raised over its rushed manufacturing and quality standards by the US drug regulator. With Novavax facing hurdles in proving it can manufacture its Covid-19 vaccine that meets regulator’s quality standards, the launch of Covovax in …

Serum Institute seeks DCGI nod for Covid vaccine Covovax
3 years, 1 month ago

Serum Institute seeks DCGI nod for Covid vaccine Covovax

India Today  

The Serum Institute of India on Friday sought permission from the Drugs Controller General of India to manufacture Covid-19 vaccine Covovax for restricted use in emergency situations at its Manjari manufacturing site, official sources said. There were no safety concerns arising from the study data and Covovax is safe and immunogenic in the adult population, Prakash Kumar Singh, Director, Government …

Narendra Modi meets Indian COVID-19 vaccine makers, lauds them for 'big role' in country's success
3 years, 2 months ago

Narendra Modi meets Indian COVID-19 vaccine makers, lauds them for 'big role' in country's success

Firstpost  

Representatives from seven vaccine makers — Serum Institute of India, Bharat Biotech, Dr Reddy’s Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech — participated in the meeting Prime Minister Narendra Modi on Saturday met Indian COVID-19 vaccine manufacturers who said his leadership was a key factor in India being able to administer 100 crore doses of the jabs …

Awaiting Govt Nod on Exports, Won't Rush Vaccine for Kids: Adar Poonawalla - News18
3 years, 2 months ago

Awaiting Govt Nod on Exports, Won't Rush Vaccine for Kids: Adar Poonawalla - News18

News 18  

Pune-based Serum Institute of India could export 2 to 3 crore Covid-19 vaccine doses to WHO-backed COVAX by November and December, the company’s chief Adar Poonawalla told News18.com. The manufacturer of Covishield, the vaccine which became the backbone of India’s vaccination drive against Covid-19, SII has boosted its production capacity to 22 crore doses per month. “That said, based on …

India Ships Vaccines to Nepal, Bangladesh, Myanmar and Iran under 'Vaccine Maitri'
3 years, 2 months ago

India Ships Vaccines to Nepal, Bangladesh, Myanmar and Iran under 'Vaccine Maitri'

News 18  

India has recently sent crores of Covid vaccine shots to four nations in its neighborhood under the “Vaccine Maitri” programme, it was announced on Thursday. Ministry of External Affairs spokesperson Arindam Bagchi said that India has exported the Covid vaccines to Nepal, Bangladesh, Myanmar, and Iran and its “top priority” is the neighborhood countries. India resumed vaccines export in the …

India May Speed Up Covid-19 Vaccine Exports Under Maitri Programme By December
3 years, 2 months ago

India May Speed Up Covid-19 Vaccine Exports Under Maitri Programme By December

News 18  

Anticipating excess stock of Covid-19 vaccines, India may accelerate the export under its humanitarian initiative — Vaccine Maitri — by December, News18.com has learnt. “As soon as we will get into a situation where we will have vaccine stock more than the requirement of Indian population, we will accelerate the exports to serve the requirement of other nations,” a senior …

Centre permits export of 40 lakh doses of Covid-19 vaccine Sputnik Light manufactured in India to Russia
3 years, 2 months ago

Centre permits export of 40 lakh doses of Covid-19 vaccine Sputnik Light manufactured in India to Russia

India Today  

The government has permitted the export of Russia's single-dose Covid-19 vaccine Sputnik Light domestically produced as the jab has not yet been approved for emergency use in India, sources said on Sunday. Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V, which is being used in India's anti-Covid inoculation programme after getting emergency use authorisation from …

India Allows Export of Russia’s Sputnik Light Covid Jab Produced by Hyderabad’s Hetero Biopharma
3 years, 2 months ago

India Allows Export of Russia’s Sputnik Light Covid Jab Produced by Hyderabad’s Hetero Biopharma

News 18  

The government has permitted the export of Russia’s single-dose COVID-19 vaccine Sputnik Light domestically produced here, Sputnik V confirmed on Sunday. Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V which is being used in India’s anti-COVID inoculation programme after getting emergency use authorisation from India’s Drug Regulator in April. The Russian ambassador had urged the …

Govt allows export of Russia’s Sputnik Light Covid-19 vaccine made in India
3 years, 2 months ago

Govt allows export of Russia’s Sputnik Light Covid-19 vaccine made in India

Live Mint  

New Delhi: The government has permitted the export of Russia's single-dose COVID-19 vaccine Sputnik Light domestically produced here as the jab has not yet been approved for emergency use in India, sources said on Sunday. Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V which is being used in India's anti-COVID inoculation programme after getting emergency …

WHO 'Deeply Concerned' Over Covid Vaccines Approved for Emergency Use Not Being Recognised in All Countries: Official
3 years, 2 months ago

WHO 'Deeply Concerned' Over Covid Vaccines Approved for Emergency Use Not Being Recognised in All Countries: Official

News 18  

The World Health Organisation is deeply concerned that COVID-19 vaccines that have proven to be effective and have been approved by the global health body for emergency use are not being recognised in all countries, an official said on Thursday. Addressing a press briefing, Dr Bruce Aylward, Senior Advisor to WHO Director General Dr Tedros Adhanom Ghebreyesus, said the organisation …

WHO 'deeply concerned' over Covid vaccines approved for emergency use not being recognised in all countries
3 years, 2 months ago

WHO 'deeply concerned' over Covid vaccines approved for emergency use not being recognised in all countries

India TV News  

The World Health Organisation is “deeply concerned” that COVID-19 vaccines that have proven to be effective and have been approved by the global health body for emergency use are not being recognized in all countries, an official said on Thursday. Addressing a press briefing, Dr. Bruce Aylward, Senior Advisor to WHO Director-General Dr. Tedros Adhanom Ghebreyesus, said the organization again …

Discover Related